A randomised trial of nicotine assisted reduction to stop in pharmacies - the redpharm study

BMC Public Health

Paul Aveyard³  Rachel Bridson³  Sarah Clarke³  Mahendra Patel¹  Jean-Francois Etter⁴  Tim Coleman²  Susan MacAskill⁵  Taina Taskila³ 

[1] University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK;Division of Primary Care, University of Nottingham, D1417, Medical School, Queen's Medical Centre, Nottingham NG7 2UH, UK;UK Centre for Tobacco Control Studies, Primary Care Clinical Sciences, School of Health and Population Sciences, Primary Care Clinical Sciences building, University of Birmingham, Birmingham B15 2TT, UK;University of Geneva, CMU, Institute of Social and Preventive Medicine, 1 rue Michel-Servet, CH-1211, Geneva 4, Switzerland;Institute for Social Marketing, University of Stirling and Open University, Stirling FK9 4LA, Scotland, UK

关键词: Harm Reduction;    Pharmacists;    Randomized;    Controlled Clinical Trials;    Tobacco Dependence;    Smoking;   

Others  :  1163793
DOI  :  10.1186/1471-2458-12-182

 received in 2012-02-01, accepted in 2012-03-12,  发布年份 2012

【 摘 要 】

Background

Public policy and clinical treatment in tobacco addiction in the UK has focused on cessation: an abrupt attempt to stop all cigarettes. However, recent evidence suggests that allowing more gradual withdrawal from tobacco or even permanent partial substitution by nicotine replacement therapy (NRT) could lead to net benefits to public health. No jurisdiction has introduced smoking reduction programmes in normal clinical care and the best methods for their implementation is uncertain. Community pharmacists offering smoking cessation services in the UK are ideally placed to implement reduction programmes.

This pilot study aims therefore to examine the feasibility of implementing smoking reduction programme in pharmacies, and also to see if behavioural support and a longer treatment affect the success rate for cessation.

Design and methods

This is a 2 × 2 randomised factorial trial of behavioural support versus no support and short versus standard length reduction programme. The pharmacists will recruit 16 patients per pharmacy, 160 smokers altogether. Pharmacists will randomise each participant by sealed envelopes. In a standard supported programme, the pharmacist will give support for 34 weeks, inviting participants to set a treatment goal and providing advice on how to reduce cigarette use. Participants in the short programme will be given the same advice on how to reduce but will reduce smoking over four weeks. Participants in the no support arms will be given a leaflet that describes the reduction programmes in 4-week and 34-week format. All participants are encouraged to use of NRT to support the reduction. These processes will be measured by recording the number of recruited smokers; percentage of those who reduce and sustain their consumption to at least 50% of baseline value, and the proportion of people who attain 4 weeks abstinence and 6 months abstinence. Interviews will assess smokers' and pharmacists' views on the way the programme ran.

Discussion

This is a pilot study to assess the feasibility of offering smoking reduction programme within pharmacies that offer naturalistic setting to show population benefit from these programmes. Findings from this trial will inform the development of evidence-based treatment for smokers who want to reduce and best approaches to engage reluctant quitters onto the programme.

Trial Registration

Current Controlled Trials ISRCTN 2010-019259-24

【 授权许可】

   
2012 Taskila et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]West R: Smoking and smoking cessation in England. 2006, 1-4.
• [2]Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton PM: Nicotine replacement therapy assisted reduction to stop smoking: A systematic review and meta-analysis of effectiveness and safety. BMJ 2009, 338:b1024.
• [3]Wang D, Connock M, Barton PM, Fry-Smith A, Aveyard P, Moore D: Cut down to quit with nicotine replacement therapies (NRT) in smoking cessation: Systematic review of effectiveness and economic analysis. Health Technol Assess 2008, 12(2):1-156.
• [4]Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ: Treating tobacco use and dependence: update. U S Department of Health and Human Services 2008, 2008:1-256.
• [5]ASH L: Nicotine assisted reduction to stop (nars), guidance for health professionals on this new indication for nicotine replacement therapy. [http://www ash org uk/html/cessation/Smoking%20reduction/NARS051014 pdf] webcite 2005.
• [6]Lancaster T, Stead LF: Individual behavioural counseling for smoking cessation. The Cochrane Database of Systematic Reviews: Reviews 2005 Issue 2 John Wiley & Sons, Ltd Chichester
• [7]Stead LF, Lancaster T: Group behaviour therapy programmes for smoking cessation. The Cochrane Database of Systematic Reviews: Reviews 2005 Issue 2 John Wiley & Sons, Ltd Chichester
• [8]Shiffman S, Ferguson SG, Strahs KR: Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. Am J Prev Med 2009, 36(2):96-104.
• [9]Haustein KO: A double blind randomized placebo controlled multicenter trial of nicotine chewing gum in smoking reduction. Pharmacia (Report) 2002, (1):1-285.
• [10]O'Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT: Educational outreach visits: effects on professional practice and health care outcomes. In Cochrane Database Syst Rev: Issue 4. Ltd Chichester: John Wiley & Sons; 2007.
• [11]Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE: Measures of abstinence in clinical trials: issues and recommendations. Nicotine & Tobacco Research 2003, 5(1):13-25.
• [12]West R, Hajek P, Stead L, Stapleton J: Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005, 100(3):299-303.
• [13]Lindson N, Aveyard P, Hughes J: Reduction versus abrupt cessation in smokers who want to quit. In Cochrane Database of Systematic Reviews: Issue 3. Ltd Chichester: Wiley& Sons; 2010.
• [14]Riggs RL, Hughes JR, Pillitteri JL: Two behavioral treatments for smoking reduction: a pilot study. Nicotine Tob Res 2001, 3(1):71-76.
• [15]Cinciripini PM, Wetter DW, McClure JB: Scheduled reduced smoking: Effects on smoking abstinence and potential mechanisms of action. Addict Behav 1997, 22(6):759-767.
• [16]Hughes JR, Callas PW, Peters EN: Interest in gradual cessation. Nicotine &am. Tobacco Research 2007, 9(6):671-675.
• [17]Shiffman S, Hughes JR, Ferguson SG, Pillitteri JL, Gitchell JG, Burton SL: Smokers' interest in using nicotine replacement to aid smoking reduction. Nicotine & Tobacco Research 2007, 9(11):1177-1182.
• [18]Aveyard P, Wang D, Connock M, Fry-Smith A, Barton P, Moore D: Assessing the outcomes of prolonged cessation-induction and aid-to-cessation trials: floating prolonged abstinence. Nicotine Tob Res 2009, 11(5):475-80.
• [19]Etter JF: Informing smokers on additives in cigarettes: A randomized trial. Patient Educ Couns 2007, 66(2):188-191.
• [20]Pope C, Mays N: Qualitative Research: Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ 1995, 311(6996):42-45.
• [21]Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D: Framework for design and evaluation of complex interventions to improve health. BMJ 2000, 321:694-696.
• [22]Creswell JW: Qualitative inquiry and research design: choosing among five traditions. Sage Publications: California; 1998.
• [23]Miles MB, Huberman AM: Qualitative data analysis. California: Sage Publications: California; 1994.
• [24]National Institute for Health and Clinical Excellence (NICE): Guidance on smoking cessation (Report). 2008.
• [25]Stead LF, Perera R, Bullen C, Mant D, Lancaster T: Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews: 2008 Issue 1 John Wiley & Sons, Ltd Chichester
• [26]Fagerstrom KO, Hughes JR: Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a review. Nicotine & Tobacco Research 2002, 4(Suppl 2):73-79.
• [27]Etter J-F, Laszlo E, Zellweger J-P, Perrot C, Perneger TV: Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: A randomized trial. J Clin Psychopharmacol 2002, 22(5):487-495.
• [28]Aveyard P, Brown K, Saunders C, Alexander A, Johnstone E, Munafo M: A randomised controlled trial of weekly versus basic smoking cessation support in primary care. Thorax 2007, 62:898-903.
• [29]Shiffman S: Use of more nicotine lozenges leads to better success in quitting smoking. Addiction 2007, 102(5):809-814.